AU2002362040A8 - Reverse micelle compositions and uses thereof - Google Patents

Reverse micelle compositions and uses thereof

Info

Publication number
AU2002362040A8
AU2002362040A8 AU2002362040A AU2002362040A AU2002362040A8 AU 2002362040 A8 AU2002362040 A8 AU 2002362040A8 AU 2002362040 A AU2002362040 A AU 2002362040A AU 2002362040 A AU2002362040 A AU 2002362040A AU 2002362040 A8 AU2002362040 A8 AU 2002362040A8
Authority
AU
Australia
Prior art keywords
reverse micelle
micelle compositions
compositions
reverse
micelle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002362040A
Other versions
AU2002362040A1 (en
Inventor
Panos P Constantinides
Likan Liang
Eun-Hyun Jang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DOR Biopharma Inc
Original Assignee
DOR Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DOR Biopharma Inc filed Critical DOR Biopharma Inc
Publication of AU2002362040A1 publication Critical patent/AU2002362040A1/en
Publication of AU2002362040A8 publication Critical patent/AU2002362040A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0291—Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
AU2002362040A 2001-12-03 2002-12-03 Reverse micelle compositions and uses thereof Abandoned AU2002362040A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US33647101P 2001-12-03 2001-12-03
US60/336,471 2001-12-03
US35472002P 2002-02-05 2002-02-05
US60/354,720 2002-02-05
US37767402P 2002-05-03 2002-05-03
US60/377,674 2002-05-03
PCT/US2002/038474 WO2003047494A2 (en) 2001-12-03 2002-12-03 Reverse micelle compositions and uses thereof

Publications (2)

Publication Number Publication Date
AU2002362040A1 AU2002362040A1 (en) 2003-06-17
AU2002362040A8 true AU2002362040A8 (en) 2003-06-17

Family

ID=27407121

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002362040A Abandoned AU2002362040A1 (en) 2001-12-03 2002-12-03 Reverse micelle compositions and uses thereof

Country Status (2)

Country Link
AU (1) AU2002362040A1 (en)
WO (1) WO2003047494A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1706098A4 (en) * 2003-11-26 2012-08-15 Supernus Pharmaceuticals Inc Micellar systems useful for delivery of lipophilic or hydrophobic compounds
BR112012016853A2 (en) 2010-01-12 2017-10-17 Novo Nordisk As "pharmaceutical compositions for oral administration of insulin peptides".
ES2631458T3 (en) 2010-03-04 2017-08-31 Interna Technologies B.V. MRNA molecule defined by its source and its therapeutic uses in cancer associated with EMT
DE102010013064A1 (en) * 2010-03-26 2011-12-15 Gabriele Blume Novel carrier system for the transport of active ingredients into the skin
CA2804599C (en) 2010-07-06 2023-01-31 Interna Technologies Bv Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway
EP2474617A1 (en) 2011-01-11 2012-07-11 InteRNA Technologies BV Mir for treating neo-angiogenesis
US10174314B2 (en) 2011-12-22 2019-01-08 Interna Technologies B.V. MiRNA for treating head and neck cancer
EP2917348A1 (en) 2012-11-06 2015-09-16 InteRNA Technologies B.V. Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated b-raf pathway
EP2946788A1 (en) 2014-05-23 2015-11-25 Immundiagnostik AG Method and composition for treating heart failure with preserved ejection fraction
KR101988240B1 (en) * 2017-02-27 2019-06-12 주식회사 디알나노 Methylene blue complex for treating skin disease and its use thereof
CN106983720A (en) * 2017-05-19 2017-07-28 浙江工业大学 A kind of reverse micelle includes the preparation method of insulin system
US11497762B2 (en) 2017-11-03 2022-11-15 Interna Technologies B.V. MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation
CN111012758B (en) * 2019-12-31 2021-10-15 浙江工业大学 Preparation method of nattokinase microcapsule

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292499A (en) * 1990-09-11 1994-03-08 University Of Wales College Of Cardiff Method of preparing medical aerosol formulations including drug dissolved in reverse micelles
EP0580778B1 (en) * 1991-04-19 1999-08-11 LDS Technologies, Inc. Convertible microemulsion formulations
US5451569A (en) * 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
US20010025046A1 (en) * 1999-06-24 2001-09-27 Rong(Ron) Liu Self-emulsifying systems containing anticancer medicament

Also Published As

Publication number Publication date
WO2003047494A3 (en) 2003-09-25
AU2002362040A1 (en) 2003-06-17
WO2003047494A2 (en) 2003-06-12

Similar Documents

Publication Publication Date Title
AU2002357119A8 (en) Mitocidal compositions and methods
AU2001294814A1 (en) Pumpcn compositions and uses thereof
HUP0301201A3 (en) Methods and compositions utilizing quinazolinones
EP1463742A4 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
EP1402001A4 (en) Anti-microbial peptides and compositions
EP1251953A4 (en) Rheology modified compositions and modification agents
EP1408978A4 (en) Novel phenylamino-pyrimidines and uses thereof
HK1071394A1 (en) Sealing composition and its use
GB0108470D0 (en) Pharmaceutical compositions and their use
IL154553A0 (en) Urocortin-iii and uses thereof
AU2002362040A8 (en) Reverse micelle compositions and uses thereof
EP1450610A4 (en) Probiotic compositions
AU2002357748A8 (en) Osteopontin-related compositions and methods
IL162083A0 (en) Catheter composition and uses thereof
HUP0600303A2 (en) Pentafluorpropane based compositions
GB0027391D0 (en) Films and compositions
EP1390074A4 (en) Novel compositions and uses therefor
EP1408985A4 (en) Novel pyridopyrimidones and uses thereof
IL153176A (en) Phenylpiperazines and pharmaceutical compositions comprising them
GB0013503D0 (en) Pharmaceutical compositions and their uses
EP1402892A4 (en) Antiinflammatoric and antitussive compositions
GB0207224D0 (en) Tenascin-W compositions and uses thereof
AU2002359869A8 (en) Pak5-related compositions and methods
GB0124023D0 (en) Novel compositions and use
GB0129258D0 (en) Pharmaceutical compositions and their uses

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase